Form 8-K - Current report:
SEC Accession No. 0001607062-23-000342
Filing Date
2023-06-26
Accepted
2023-06-26 12:51:38
Documents
13
Period of Report
2023-06-26
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K sybleu062623form8k.htm   iXBRL 8-K 40267
2 EXHIBIT 10.1 ex10_1.htm EX-10.1 59965
  Complete submission text file 0001607062-23-000342.txt   286706

Data Files

Seq Description Document Type Size
3 XBRL SCHEMA FILE sybleu-20230626.xsd EX-101.SCH 3215
4 XBRL LABEL FILE sybleu-20230626_lab.xml EX-101.LAB 34240
5 XBRL PRESENTATION FILE sybleu-20230626_pre.xml EX-101.PRE 22349
7 EXTRACTED XBRL INSTANCE DOCUMENT sybleu062623form8k_htm.xml XML 3280
Mailing Address 1034 THROGGS NECK EXPRESSWAY BRONX NY 10465
Business Address 1034 THROGGS NECK EXPRESSWAY BRONX NY 10465 718-795-7790
SYBLEU Inc (Filer) CIK: 0001818674 (see all company filings)

EIN.: 851412307 | State of Incorp.: WY | Fiscal Year End: 0630
Type: 8-K | Act: 34 | File No.: 333-248059 | Film No.: 231041059
SIC: 2834 Pharmaceutical Preparations